EMN

Image source: The Motley Fool. Friday, July 31, 2026 at 8:00 a.m. ET Board Chair and Chief Executive Officer - Mark Costa Executive Vice President and Chief Financial Officer - Willie McLain Eastman Investor Relations - Greg Riddle Operator: Good day, everyone, and welcome to the Second Quarter 2026 Eastman Conference Call. Today's conference is being recorded. This call is being broadcast live on the Eastman website at [www.eastman.com](https://www.eastman.com). I will now turn the call over to Mr. Greg Riddle, Eastman Investor Relations. Please go ahead, sir. Greg Riddle: Thank you, Lucy, and good morning, everyone, and thanks for joining us. On the call with me today are Mark Costa, Board Chair and CEO; Willie McLain, Executive Vice President and CFO. Yesterday, after market close, we posted our second quarter 2026 financial results news release and SEC 8-K filing, our slides and the related prepared remarks in the Investors section of our website, eastman.com. Before we begin, I'll cover 2 items. First, during this presentation, you will hear certain forward-looking statements concerning our plans and expectations. Actual events or results could differ materially. Certain factors related to future expectations are or will be detailed in our second quarter 2026 financial results news release during this call, in the preceding slides and prepared remarks and in our filings with the SEC, including the Form 10-Q to be filed for second quarter 2026 and the Form 10-K filed for full year 2025. Second, earnings referenced in this presentation excludes certain noncore and unusual items. Reconciliations to the most directly comparable GAAP financial measures and other associated disclosures, including a description of the excluded and adjusted items, are available in the second quarter 2026 financial results news release. As we posted the slides and accompanying prepared remarks on our website last night, we will go now straight into Q&A. Lucy, please let's get started with our first question. Patrick Cunningham: Just on Advanced Materials, pretty solid volume and mix growth in the second quarter. You mentioned some offsets from lower OEM production, weak aftermarket durables. I guess how should we think about the recovery trajectory of these weaker end markets heading into '26 and the sustainability of this volume growth and confidence in ultimately a stronger second half? Mark Costa: Sure, Patrick. And I have to say I'm really incredibly excited to be talking about the company today and the tremendous execution our teams are doing across all businesses. It's really been a great result in Q2. And now we're looking at how we move forward in Q3 and the back half, I think, is an important conversation. What I'd say when you think about the back half of the year, we're not expecting any improvement in the end markets when it comes to sort of the weak discretionary markets, auto, B&C, consumer durables. We're certainly benefiting from modest growth in what we call our stable markets across the entire portfolio. And so we're not really seeing any sort of changes there, and we're not seeing any impact of the Middle East war yet on sort of hurting end market demand in a material way across the world as far as we can see it right now. So in that context, I think we're really well positioned to grow earnings, not just for Advanced Materials, but for the corporation as we look at the back half of the year. Starting with Advanced Materials, what you can certainly see is the volume growth has been strong into Q2, which is driven by a lot of wins in the marketplace, innovation-driven wins and the growth that we're having in the circular business is still somewhat modest and will ramp up into the back half of the year. So you'll see the Renew volumes continue to ramp up. You'll see we'll continue to win in marketplaces through innovation, which would offset what is a normal volume decline in the back half for AM. We won't see that. Volumes are more likely to be similar to the first half. So that's actually a good, solid base to build from. And then on top of that, with Advanced Materials, you've got asset utilization tailwinds that are coming from all the actions we took. And we mentioned in the prepared remarks where we reduced finished goods in the front half to offset some of the raw materials we were buying like paraxylene to make sure we had security of supply. That created a bit of a utilization headwind in the first half. That will sort of flip around to being a tailwind as these markets remain solid and we have to ramp up production. In fact, we're really excited that the Tritan line is coming online now because we are pretty limited on capacity with Tritan with the volumes we had in Q2 and how we've switched one of our Tritan lines to serve the PET growth. So that's coming on just at the right time. And now we're taking our paraxylene that we bought in advance for supply reasons and converting into finished goods in the back half of the year. So it gives you a tailwind on utilization, but not a headwind on cash. So that's all going well. And then on the price/cost side, team has done a phenomenal job of getting prices up with raw materials. And as they've caught up, that will now flip into a tailwind in the back half of the year, also helping AM have solid earnings growth into the back half of the year, which is not our typical pattern. So that's great to see that strength build. The second driver I would just mention to finish off the story is fibers. The tow volumes will increase in the back half of the year materially as customers are increasing their orders to meet their annual minimum volume commitments with us. So that's coming through, and there'll be some textile recovery we see as well because volumes are quite low in the first half of the year and some of the wins we're having will start bringing us back to sort of full volumes relative to last year. There will be some offsets, obviously, in Chemical Intermediates and how those margins may moderate with the state of the Middle East conflict. What I'd say on that front, though, is it's pretty uncertain what's going to play out right now. But right now, we're expecting some moderation. And then Additives & Functional Products will have some seasonal decline like normal. So when you put it all together, we're really in a good position to deliver a good strong earnings improvement relative to last year. We basically had a strong beat in Q2. We're talking about a very solid Q3. And so when I think about our view on earnings for the full year today, I would say that it's better than where we were in April and certainly feel like we're on a good track to very strong earnings growth in this context. Patrick Cunningham: Got it. And then maybe just a follow-up on Chemical Intermediates. I think the direction and magnitude of spread changes is anyone's guess at this point, but you had a pretty robust volume increase in the quarter. I guess what sort of dynamics drove this volume surge? And how much of it was realizing some of those durable share gains you alluded to last quarter versus maybe some temporary pull forward there? Mark Costa: Yes. So on Chemical Intermediates and volumes, the vast majority of the volume increase was driven by -- on a year-over-year basis, a lack of significant shutdowns this year relative to what we had last year. Last year, we had planned shutdowns and some unplanned shutdowns. And so we lost a lot of capacity to sell in the market. This year, the volumes are running at normal capacity, which is a lot better than where we were. That does include some pickup in share due to the supply tightness in the marketplace. That's a quality of earnings comment, which is we're always going to sell the volume. It's just where do we sell and what the margins are. In North America, we picked up some share where the margins are much more attractive than the export markets. Obviously, at the moment, the export markets are also very attractive and we picked up some volumes in some attractive spots around the world where we saw opportunity to capture that value given the disruptions in the marketplace. So the volumes are very good, but it's more about mix quality and the tightness in the spreads that stacked on top of that. We also emptied out the cavern on ethylene at very attractive prices. So we had some stored up ethylene that we sold off in the marketplace. Joshua Spector: I wanted to follow up on Advanced Materials volumes. So I mean, obviously, a solid quarter this quarter with the 5% growth you had. I'm wondering, one, can you split that between what you call the base business versus the methanolysis PRT contribution? And then in your comments on 3Q, it seems like you're talking about volumes flat, but the comp is really easy. So I'm not sure what you're baking in there versus a year ago and why volumes wouldn't be up? I'm obviously missing something, so if you can help me there. Mark Costa: Let me just start clarifying what I said. Volumes flat is a sequential comment, Josh. It will be substantially higher than last year. So we were just talking about volumes will be similar to Q2 in Q3. So in that context, which is much higher than last year, the volumes -- a lot of it is wins we've had. On the Renew side, it's important to note that the growth we're seeing this greater than $100 million, which is incredibly strong in the first half, double revenue compared to last year is evenly split roughly between specialty growth and rPET. So we are seeing continued wins and growth in the specialty side of the house. And we are also seeing the PT wins happening as well and ramping up. And I would say more of the front half is on the specialty side. The back half is more on the PT side as we're ramping up those capacities to serve the market. We've been a bit challenged on some of the production capability and getting it fully lined out, which is part of why we reduced the revenue outlook is capacity constraints and a little bit of slowness in the market, but still incredibly strong growth relative to last year. So we don't really break out in detail by quarter what is going to be Renew versus the rest of our business. But what I can tell you is when you look at the full year, about half of the revenue growth in the Advanced Materials segment is going to be from Renew and about half is going to be from specialty growth. So that also says great that circular is kicking in, great that it's delivering additional growth with that growth platform, but also the specialty businesses are healthy. And through innovation, not in market demand, we're creating our own growth and success across the marketplace. One of the great stories in that is actually performance films. So in the first quarter, earnings were quite challenged in the segment level. That was mostly due to films and in particular, performance films. And we took a series of actions that were very successful. So we launched a better, broader market strategy to win share in China. That's been incredibly successful as we move from Q1 to Q2. And also, we took out and optimized a bunch of capacity to optimize what we make in North America and ramp up our asset in China, which is a much lower cost asset. So big improvement in cost structure. So that led to pretty a big part of the improvement in earnings from Q1 to Q2. It also means when you get to 2027, we're going to have an easy comp and probably do $25 million to $30 million better in Q1 next year relative to this year. So a good adder for next year as well. Joshua Spector: Okay. That's helpful. And I apologize on the sequential versus year-on-year here. I guess you made an interesting comment on the PRT side or some of the rPET wins you're trying to go for. You talked about it being more capacity and ramp-up. I guess in your comments when you -- or your prepared remarks when you updated on the circular growth, you seem to talk more about consumer demand. I guess, which is the bigger factor to your adjustment of your growth? Is it the consumer demand? Or was it your ability to supply? Mark Costa: I'd say it's a bit half and half. So there were some limitations on production on the rPET side. We're not changing the outlook that much. We've just brought the revenue outlook to be a bit below the range we gave you earlier. And then I would just say it's a little bit of slowness everywhere about the rate at which customers are ramping up on specialty and some of the rPET purchases. I mean the economy is incredibly weak right now. We're not seeing anyone back away from their commitments to recycled content and seeing the value of it. But all of our brands, as you guys know from earnings calls, are struggling out there, whether it's on the consumer durable side or on the consumer packaging side. The economy is tough. People are very focused on managing costs. So they're being extremely disciplined on what premiums they pay. And I find incredibly encouraging that we've held on to our specialty customers who are paying premiums in this marketplace and that we're still growing it. I feel very good that we see a ramp-up in rPET in this kind of market context, which says people really see the value, the need of it because we have a superior product and quality and clarity. And that's incredibly important for durables always, but also important for these consumer packaged goods companies. So we're very encouraged about the confirmation of our value proposition, and we're all just stuck in a weak economy waiting to find ways to keep growing. David Begleiter: Mark, just on Additives & Functional Products, very resilient margins in the face of really challenging end markets. Can you talk to what's underpinning those resilient margins and maybe views on the back half of the year for those margins? Mark Costa: Sure. Yes. So Additives & Functional Products has been a phenomenal success story for us. And it's a tribute to a phenomenal team, a great set of products and markets and just great execution every day. So the benefit that Additives & Functional Products has versus AM is the stable markets that we serve are 2/3 of our revenue. So with stability, it becomes much calmer behavior by everyone involved. And so in that sense, whether it's in pharma, whether it's in water treatment, ag, personal care, these series of very stable markets, aviation, we've got great industry structures. We've got very strong competitive positions and a lot of cost pass-through contracts associated with some of these businesses that give you a lot of margin stability. So the CPTs will fluctuate quarter-to-quarter on headwinds and tailwinds to some degree. But on an annual basis, it provides a lot of margin stability. So you've got these businesses that have solid moderate growth. You've got great industry structures and the products we have in this business and their stability. CPT is adding to that margin stability on top of it. And where we don't have CPTs, teams have done very good work in raising prices consistent with raws and materials as well in this environment as we went into sort of Q2 and holding those margins in the back half of the year. So it's just been a great solid business. David Begleiter: Very good. And just on Kingsport methanolysis, do you have an early view on revenue growth in 2027 from that plant and product line? Mark Costa: Well, I'm not going to give you a specific number, Josh. But I mean -- David, sorry. But what I would say is we're building up revenue momentum through the year. So Q4 will be the strongest revenue quarter when you think about that $100 million this year. And of course, that will then annualize into next year. And then we will build on it. And I would expect the same kind of build next year on the specialty side of the revenue as we continue to win business in that -- in this environment. And the PET side, I think, is well positioned for strong growth next year, but we need to see how that all plays out as we go through the back half of the year. But I would expect it's another strong performance next year on top of this year. Frank Mitsch: Mark, one of the more impressive things about the quarter is what you've done on price cost in the specialties businesses. I mean, typically, we think of those as being priced for value and use and so forth. But obviously, this is a somewhat unusual environment. Can you talk about what's been going on, on the cost side in the specialties business and how you're able to get price ahead of that? Mark Costa: Well, Frank, thanks for the question. And I think one of the strengths Eastman has had for a very long time is our discipline around price cost management. I think we've done an excellent job through the years, whether it was catching up to raw material increases in '21 or maintaining great price discipline when markets are softening and holding on to value in those context. I'm incredibly proud of our teams and how they did it. And as always, once the war started, they moved immediately into action and taking the price increases necessary across the markets in both of the specialty businesses. What I'd say is that we succeeded in getting the prices in. We weren't greedy. We just put in price increases to cover our raw material and energy and distribution costs because we want to be fair and reasonable to our customers. And we're not going to sort of eat those costs, but we're also not going to try and take advantage of a lot of other companies, I think, get aggressive in these times. we had some feedback where we are being disciplined in how we did that gives us a lot more credibility and durability in those price increases, not just in getting them increased, but into holding on to them. The business is centered around driving value through volume growth and mix uplift and our innovation. And -- but we do a very good job of keeping our variable margin per kg pretty consistent and attractive. In fact, through all this chaos, that's been relatively stable since 2019 to now. And it's a testament just to the quality of products and the innovation we have in the marketplace. You can only do that if the value of your products are meaningful to your customers. And so when we can increase prices like this, it's a good proof point around these are specialty products that have value that customers will pay a higher price because they need them because of what we do in their products and how we create value for them. And so I think that's a great way to test your portfolio, and I think we are passing that test really well in Advanced Materials and AFP. Frank Mitsch: So certainly loss have been fairly volatile. And every time there's a peace proclamation, you tend to see it go down and then it reverses the other way. Can you talk about the sustainability of that price cost into the third quarter or probably said another way, how do you compare your July margins with the second quarter average, if you could offer us that? Mark Costa: Frank, you're asking about the specialties, just to clarify. Frank Mitsch: Yes. That's exactly specialties, yes. Mark Costa: Chemical Intermediates is a very different conversation. So on the specialties, our intention is to keep the prices in place. The raw material cost and energy costs as well as distribution costs are still flowing through. And so we would maintain good price discipline in these businesses as we -- as those higher costs flow through. So what will happen is prices will hold. The raw material costs are probably a little bit less than they were in March at this point, obviously, if you go look at things like paraxylene, but we still have a lot of flow-through. But on a year -- I mean, on a first half, second half basis, the price discipline we have in July and expect to continue as we go forward will give us a tailwind on price cost in the second half relative to the first half. Jeffrey Zekauskas: Mark, over time, Eastman has really been focused on investing in methanolysis in Kingsport, Texas and Europe. And those plans have altered in part because of what customers want, what the government wants, what capital costs are like. And so when you look at the trajectory of your capital expenditures, your R&D, your investments, I would imagine that those have really shifted because of the delays or obstacles that have been put in place that have inhibited investment in methanolysis over a longer period of time. So maybe if you could sort of briefly talk about the redirection of Eastman over a longer period of time. Mark Costa: Jeff, thank you for the question. Yes. So I actually wouldn't support your characterization. So the way we look at it is, I think, considerably different. Methanolysis, I think, has been a great platform and a great investment. We see a lot of long-term potential for the platform. Without a doubt, when you start a platform like this in a very strong economy like we had in '21 and the beginning of '22, and then you get to a much weaker economy, it's easy to sort of look back and sort of review did we make the right set of choices. At the same time, you can't just sit here and look at the world you live in at this moment. You also have to look at the future. And I think we believe that at some point, the economy will be healthy again. And in that context, where there's some health in the economy and everyone is not just focused on cost reduction, we'll see a pretty significant acceleration in demand for Renew products when it comes to the revenue side of this question. Both recovery in the consumer durable market will naturally give a huge lift to Renew as well as -- like I said earlier, we're not seeing anyone back off on the value of recycled content. I mean plastic waste is an issue in the world is not going away. And it's not a bipartisan issue for the Democrats versus Republicans. Everyone hates plastic waste. No one likes it. No one wants it in the environment. People are worried about its impact on their health. This issue is not at all going away and every brand knows it. They're just trying to figure out how they manage taking responsibility for the polymers that they put in their products relative to cost management here in the short term. So our confidence in revenue here, both on the specialty side and on the rPET side is great, even greater on the rPET side because we're proving that we have superior quality and clarity to mechanical every day in a pretty significant way that's being recognized in the marketplace. So actually, my point of view about the value proposition on the rPET side is much stronger today than it was a year ago, and what we're seeing in our relative value recognition in the marketplace. I mean think about how much rPET increases are going on this year with our key customers in this market context. So revenue-wise, we feel good. It's frustrating to be in this current economy for everything in the chemical industry. But it doesn't question the value proposition of why we got into this. And then when it comes to the capital side of the equation, first of all, on the technical side of the equation, the plant is running phenomenally well. So we've got a technology running that no one else in the planet can do as well as we can. I mean with our yields above 90%, with the operations running reliably now with our ability to see that we can debottleneck the plant by 30% to get more volume out of this plant and improve ROIC. It says that we have an operational and technical advantage to anyone in this world. And then on the capital efficient side, without a doubt, capital costs have gone up a lot. That's what we were sort of facing as we looked at the project in Texas. And we -- with the loss of DOE grant and us having to rethink how to approach the marketplace, we start developing a much more capital-efficient option about how to go forward. And we're getting close to talking to all of you about how that looks like in specifics, but we're not quite there yet. But we feel like we have a great path forward on a much more capital-efficient option in doing this. And because we can debottleneck Kingsport, it allows us to push out the need to spend that next chunk of capital until '28 so that we have time for the market to recover and align with that investment. Jeffrey Zekauskas: And for Willie, receivables, I think, for the first 6 months have been a use of cash of $370 million. Why is there a ballooning of receivables? What might be the penalty this year? And how much of that can you get back next year? William McLain: Thanks, Jeff, for the question. Yes, I think as Mark has already highlighted, our commercial teams have done a tremendous job on both managing price and price cost as well as volume. Our revenue is expected to be $500 million higher due to the pricing actions that we're taking this year. And ultimately, we're focused on delivering earnings and solid cash and strong cash flows in any environment. So as we look at it and as we highlighted when we talked in Q1, we expected the pathways to be narrowing. Actually, on an overall working capital, we're actually consumed a little less here in the first half than we did last year. You've heard us being disciplined on inventory, as Mark also highlighted. But as we look at that and having a stronger back half, we actually will not get as much working capital back this year as we did last year. So that's where we're -- you're seeing around roughly the call it, roughly $75 million reduction on a year-over-year basis in our, I'll call it, multiple scenarios that we're looking at. So going from $970 million to approaching the $900 million, and we feel confident that we can do that. Vincent Andrews: Mark, some moving parts in both -- in Fibers in both tow and textiles for the back half of the year. I wonder if you could just unpack those a little bit and help us understand how much of that we need to follow through into 2027. Mark Costa: Sure. So when it comes to the back half of the year for Fibers, there's -- as we've talked about, I think, extensively on the tow side, we have these annual contracts with customers, but they have the right to vary what they buy quarter-to-quarter. So they're not that good at ratability. So we had -- in the front half, customers on the tow side not buying that much. But now to hit their minimums, they're going to step up their purchases in the back half of the year to hit the what we consider sort of the low end of the volume bands that they have in their annual contracts. So I mean, that's what's happening on that front. There, of course, is a little bit of risk around the Middle East. That was an area that we -- our customers thought they were going to grow last year, didn't have that much success as we explained. They thought they're going to grow this year, not having as much success with all the Middle East disruption, highly determined to keep growing and do what it takes. So there's a little variability on that front. But I would say the tow volumes on an annual basis will turn out by the time we're done to be sort of relatively stable to last year. But that is a meaningful increase in tow purchase in the back half of the year, which we'll see a benefit of. On the textile side, it's a bit of the same thing. We thought that this year would be recovering from a very difficult year last year. We told you that we had about a $30 million headwind last year relative to '24 with the drop in the textile business, which was a combination of a weak market made even weaker by tariffs impacting demand and our price point going into China. And so that created a lot of sort of headwind for us into '25. We had a bunch of actions we were taking to improve it this year, but they have not so far been successful because the market just continues to be weak. So the first half was pretty challenging. The volumes were relatively low and a very tough comp to last year because volumes in textiles were high in the first half of last year and then really came off in the back half of last year with the tariffs. So tough comp to last year. But we are seeing some success, and we believe we'll build volume growth back in the back half of the year, which really would just get us to be even with last year. we were thinking we were going to get a $15 million tailwind this year, and it turned out to be pretty much nothing relative to last year. But it is good momentum on textiles into next year that in the wins that we're starting to sort of build on in the back half of this year. So that's to play out from this year on sort of what's going on there. Prices are not changing. They're pretty much consistent with what we thought from the beginning of the year. Energy costs are a headwind. So there's that spread compression there. And utilizations are a headwind as we manage our inventory and capacity relative to sort of this demand environment this year. So those are all sort of factored into sort of our point of view right now. When you get to next year, it's important to remember that a lot of this earnings decline from '24 to now is not actually tow. It's textiles. It's utilization hits about slow demand across the corporate stream that sort of flows into Fibers on the cellulosic stream, higher energy costs. But what we do think is plausible as we look at next year is there's a set of actions that we can take that are in our control to try and sort of stabilize this business. The demand drop isn't market related. It's -- the market is declining 1% this year in a range of a typical 1% to 2%. The drops in demand have been destocking, have been some share shifts that were principally in '25. And as we look at where we are now, we have, by far, the lowest cost position in this industry in the tow business, in the cellulosic business, and it's a very integrated advantaged cost structure at our Kingsport site. And something about the stream is that it needs to run really full to have a positive effect on economics and overall site stability. So we do see us recovering some of our market share that was sort of lost in balancing the stream in that sense. And we have all these growth programs that start kicking in. So it's recovering textiles, I just mentioned. There's things like Aventa that are moving slowly, but picking up momentum. There will be some additional volume for next year. There's some other programs we're working on that we can't really talk about right now that could be quite material to the stream. So there's a lot going on right now on actions that we're taking to make sure that the business is as stable as possible next year relative to this year. Vincent Andrews: If I could just ask you, I think in AFP, maybe a little more so than the other segments, but there's been some share gains that have come on account of maybe some competitor dislocation given the Middle East situation. What's your assumption in terms of the durability of those gains, whether it's for the back half of the year or into next? Mark Costa: I just want to clarify your question. Were you asking a volume question or a spread question? Vincent Andrews: Volume question. In terms of market share, you've had some volume share gains. I think some competitors maybe didn't have the ability to produce to the same extent, and so you've picked up a little bit of share that way. So I guess, is that correct? And then if so, what's your assumption on the durability of that? Mark Costa: Sure. So in Chemical Intermediates, I think our assumption where we've had some share gains is that it will be relatively durable volume gains in the back half of the year. I mean not gains, but we'll hold on to it in the back half of the year. I mean there may be a few places where in our export markets, we see some change of positions and where we're selling our material, but our volumes overall will hold up. It's just a question of spreads. So obviously, there's a question around just how the back half of the year may moderate in spreads in Chemical Intermediates relative to the first half with all the dynamics going on. And it's anyone's guess at this point. It's really a box of chocolates out there where every day, it's a different story, and we can see things soften or we frankly could see things stay tight depending on what happens, especially in the next couple of weeks. When it comes to the specialty side of the question, we expect to hold our market shares. We didn't see any market share losses in the first half of the year as we increased prices. We're not expecting any market share losses in the back half of the year with how we're managing our positions in our markets. And that's being disciplined in holding our price relatively well in that context. The places where we picked up share on the specialty side is pretty modest in Q2. When we look at where we thought we could get a lot of share from companies being disrupted, that hasn't played out that much yet. Companies are really holding out and using whatever inventory they have to try and hope for lower prices in the future, both on the commodity and the specialty side. That's a big part of why markets on the commodity side are weakened as everyone is leaning on inventory. China is dumping inventory that they've built up over the last 2 years. Customers are holding -- using inventory to hold out for better market conditions. At some point, all that inventory is going to run out. And if it hasn't been replaced by a lot of stability in the world in the Middle East, in particular, things that get pretty tight here in the back half of the year. So there's a wide spectrum of how this may play out. But right now, I'd say the teams are doing a phenomenal job of holding share, phenomenal job, great job of holding price. But we're not in the specialty side picking up a lot of market share yet. Abigail Eberts: Just a quick question on your cost reduction targets of $125 million to $150 million. Can you just remind us how we should be thinking about that weighted across your segments? William McLain: Thanks for the question, Abigail. And the Eastman team has done a tremendous job delivering on $125 million to $150 million net of inflation. I would also say I'm confident with what we've delivered here in the first half and actions implemented that we will deliver the second half and also shift our focus into 2027 and focused on at a minimum, offsetting the inflation. As we think about the split across the businesses, I would highlight Advanced Materials as well as Chemical Intermediates as being the two largest manufacturers and to the lesser extent, Fibers and Additives & Functional Products. John Ezekiel Roberts: Lots of new product discussion in the prepared remarks. Could you back it up to an overall company level? Where are you on your innovation index, new products as a percent of sales, however you want to define it? Mark Costa: So first of all, John, good to talk to you. We're incredibly proud of our innovation growth model. And at times like this, when markets are weak, I think we've proven we can create growth above underlying markets across the portfolio and in particular, in the Advanced Materials segment where we've made the most investments. So overall, we see, as you've noted, great growth in Tritan. We're picking up new growth in Tritan because Europe has put a ban on BPA that's driving more conversion into our product, which is great. We've launched a new cosmetic product that's recycled code 1, and that's a big deal for the cosmetic industry. So we're seeing great growth there, including Renew content being in it. You've got the HUD growth. You've got this new performance film strategy we just talked about in China that's given us significant broader addressable market growth that's been incredibly helpful. So there's a lot of things going on there. AFP is not as significant, but still meaningful when it's ultra-high purity solvents for semiconductors, which is growing very high rates right now with the market at good margins. You've got aviation continue to roll, and we've got some new products coming out soon that are a big deal for the industry. Solus cellulosics for biodegradable polymer coatings on paper for cups and packaging and things like that. So there's a lot going on. We don't really provide a revenue percent of innovation as a public statistic. But I would say it's roughly in the sort of mid-teen to 20% range when I look at it from -- in the specialty world. So we feel very good about the innovation curve that we're on. And we -- we have a lot of metrics in which we measure it. It's just we don't make those all public. John Ezekiel Roberts: Okay. And then the Kingsport coal gasifier has been a pretty valuable asset here in this high oil price environment. When is the next major planned maintenance downtime for that unit? Mark Costa: We just did it. So we had a massive shutdown of that stream in Q2, which was a big headwind from Q1 to Q2 for Fibers as well as Chemical Intermediates in that sequential result. And what I'd say is it was a very large cost. So it will not repeat next year. So there will be a tailwind next year relative to this year with that significant shutdown, helping the whole cellulose stream. Matthew DeYoe: I have 2, but I'll start with like -- can you just bridge us a bit on some of this shift from 2Q to 3Q with all these outages and then like strategic inventory management decisions, I guess I'll call it that? In general, it seems like you're able to destock your raw mats and then conceptually, it seems like you're restocking at levels in 3Q that doesn't net penalize you versus the gains from better utilization rates. Is that right? And like how much outage headwind was there ultimately in 2Q? William McLain: So Matt, thanks for the question. I think what Mark highlighted in the beginning with Advanced Materials is, obviously, we were making trade-offs with the timing of plants coming online, the Tritan facility that we highlighted as well as the escalation of the impacts in the Middle East. So we ultimately were able to bring down some finished goods inventory within our Advanced Materials business. That created a utilization headwind as we did that. And we did that to ultimately secure key feedstocks to enable us to deliver with confidence into the second half. Mark just highlighted that we had major turnarounds in Q2. As we think about from Q1 to Q2, that was around $40 million to $45 million headwind sequentially. Our original guidance was we expected to benefit about $30 million sequentially. But with the Advanced Materials pulling some turnarounds into Q3, we now expect that to be, I'll call it, closer to the $10 million to $20 million for the overall company. So those are the big shifts as you think about shutdowns and turnarounds. I would also say on a year-over-year basis, we will have substantial utilization benefit in the second half compared to last year as we had inventory corrections in Advanced Materials and across the company in the back half of last year. And you've heard Mark today talk about the strong demand outlook that we see here in Q3, and we'll continue to update you on that. But I think the big drivers are the turnarounds that I just described sequentially. Mark Costa: Yes. Just when you want to look at it from a segment point of view, there's 2 different things that Willie described. There was the finished good impact on Advanced Materials, the cellulosic shutdown that we just talked about that was very significant and actually a couple of other smaller shutdowns. But the big impact there was in Fibers and in Chemical Intermediates. So it shows up in different places, depending on which topic. Matthew DeYoe: That's helpful. And I guess, can you talk a little bit about volumes through the quarter? And really even just like if you want to bridge March into this, right? There's a lot of discussions around panic buying, downstream not, how that might have ebbed and flowed into June. And obviously, when we talk to investors, there's just concerns around customer destocking in 2H given what's happened more recently over the last few years. So how do you get confidence around this 2H volume profile? And were things trending better as you exited 2Q? Mark Costa: So great question. And certainly, volumes trended well through the quarter in Q2. So almost like a normal way, which is it sort of built from April through June. And in that sense, things actually felt quite normal despite all the chaos that surrounded us and what was going on. It is a very fair question and one that we constantly are debating internally around demand, especially after last year where you saw that build to get ahead of tariffs and then the decline in volumes in the back half. So far, we're not seeing that same dynamic. So July orders are holding up well and on track to what we would expect and consistent with what you would expect relative to Q2. So that's a good sign. When it comes to a lot of the sort of buying in CI, it's a more dynamic question. So with whatever is going on the freight. But when it comes to specialties, which I think is really where your question is centered, we're not seeing any end market demand declines or customers talking to us about that as a main concern. The customers had to -- are balancing 2 things at the same time, which I think is different than last year. Right now, they're very -- because of what happened last year, they're very disciplined through February of this year in destocking inventory and getting inventories to be really low, right? So when you got to March, obviously, there was concerns about access to raw materials, and so you saw some pickup in demand. But at the same time, worries and concerns around what could happen to the end market demand in the back half of the year, I think, has kept a lot of discipline in everyone's mind about just how much inventory they want to build. And you can debate whether they're building inventory right now or using up inventory right now, hoping for lower prices. So there's a lot of mixture going on that's very different than last year so far, where they want to have inventory, but they also want to hold out for lower prices, maybe if the Strait normalizes and everything gets more stable. So you've got a lot of opposing forces where we don't think that people are sitting on significant inventories right now in this dynamic. And if they were going to really destock, it could have started, frankly, in June when people were really optimistic in May about the Strait opening. And we didn't see that happen in June. So I think things are better positioned to be more stable. The wildcard here, of course, is if things really get out of control in the Middle East, oil prices go up dramatically, you can have a global impact on consumer demand. That's not in our forecast, that sort of extreme scenario. Kevin McCarthy: Mark, a question or 2 on your circular platform. I think you indicated in the prepared remarks that you expect sales to grow by $100 million or more this year. Can you comment on what a good contribution margin would be against that sales growth? Mark Costa: We're not going to talk about contribution margins on this business. What I can tell you is the revenue growth is attractive. The margins are certainly above company average when you think about this business. So it's a value and a mix upgrade to the company and to AM when you think about variable margins. When I think about the business and its long-term EBITDA potential, we still very much feel we're on track for this first asset to get to $200 million of EBITDA. We're not seeing any reasons why that's not going to happen. It's going to take longer than we'd like with the state of the current economy, but the value proposition, the contribution margins we see is still very attractive. Kevin McCarthy: Okay. Maybe related to that, my general impression is that the engineering team has done a great job. And if anything, you've proven out the capacity to be higher than originally expected. Obviously, the demand has trended as previously discussed. But is there a way to give us a sense of what the capacity utilization is? And I'm thinking back to your deal with Pepsi as well. How much headroom do you have to kind of load that asset moving forward? Mark Costa: So I think with what we've shared with you last year is we were around 50% utilization on the asset, and we've stepped that utilization up with the improvement in demand this year. We've also run tests to run the plant as hard as possible to understand what we think the effective capacity of the plant is and feeling very confident we can get up to 100% in running the plant to support demand growth as it comes. And then, of course, as we said, there are sort of targeted incremental capital projects to do in the plant to sort of debottleneck it up to 130% of design capacity or 130,000 tons. So in that sense, I think we feel really good about where we're at and continue to gain more insights about how to optimize the performance of the plant and its cost structure. When it comes to polymer, that's where the constraint is on the rPET side. because this plant was originally built for specialties. And as the market sort of weakened on the growth in specialties, we obviously flexed our polymer lines, which is a great advantage we have just this flexibility to flex them from Tritan to copolyester to PET. We took a Tritan line and flexed it to PET because we knew a new big line of Tritan was about to come on to serve the market that we're building. And so that was a great way to balance it out. But there's still limits to what that PET capacity is. And so we're now looking at some other polymer lines that we can optimize to continue making our PET that have some additional capacity in this current market conditions. And so that work is going on right now to enable us to keep growing the PET in a significant way next year. And then there's other things we're doing about our sort of capital-efficient model. We'll talk about in future calls about how that can support more polymer growth. Laurence Alexander: Can you touch on or give some detail on how you're thinking now about your M&A pipeline? How active is it? What are you seeing in terms of valuations? Are there strategic directions that you'd be open to considering? Just what's your positioning on that? Mark Costa: Well, first, what I'd say is I think Eastman has had a great disciplined history when it comes to portfolio management. So there are times where we divested a bunch of underperforming businesses, if you go far back in time, then there is a period of time where we got out of these underperforming businesses and did large acquisitions like Solutia, Taminco and bolt-ons that have been incredibly successful, and we did them at times when valuations were actually rational. So those big acquisitions we paid roughly 9x EBITDA for and have been huge value contributors to the company. And then we've been in a phase of optimizing and growing organic growth through innovation, which I think has been successful and proven itself in good times and bad. And we've also shown we're going to continue to be very disciplined on divestments, right? So when we had some other businesses underperforming like tires and adhesives we divested them as well as optimize our acetic acid footprint. So great discipline there and divesting things when it made sense at 10x EBITDA. So I think we've got a good track record in M&A of being very successful with it, being very disciplined when things are not working well. We definitely believe our company is at sort of minimum scale to be effective in our innovation and our balance sheet to support all the growth potential the company has. So as we look forward, we'll always be disciplined about businesses that are not performing and dealing with it. And we're always looking at M&A and considering it. Clearly, that M&A market has picked up activity this year, as you would expect in this market condition. Valuations have improved to being more rational than they have been for quite some time. So we're out there considering all of our options, like I think every company in the industry is doing today. I think we can all acknowledge that we're probably going to see a lot of change over the next several years in this industry with all the dynamics that we face. But I'm incredibly confident that we'll remain disciplined and make good choices on both sides of the fence as those opportunities come up, but I'm not going to get into details on it. Greg Riddle: Okay. Thanks again, everyone, for joining us. We appreciate you taking time to talk about Eastman this morning. Please have a great day. Operator: This concludes today's call. Thank you for your participation. You may now disconnect. Before you buy stock in Eastman Chemical, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eastman Chemical wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $397,405!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,344,091!* Now, it’s worth noting Stock Advisor’s total average return is 953% — a market-crushing outperformance compared to 214% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors. See the 10 stocks » *Stock Advisor returns as of August 7, 2026. This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Eastman (EMN) Q2 2026 Earnings Call Transcript was originally published by The Motley Fool

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Performance in Q2 was driven by innovation-led wins in Advanced Materials and strong execution across the portfolio, offsetting continued weakness in discretionary end markets like auto and consumer durables. Advanced Materials volume growth was supported by a strategic shift in production capacity, including flexing Tritan lines to serve growing rPET demand while awaiting new capacity to come online. Chemical Intermediates benefited from a lack of planned shutdowns compared to the prior year and strategic share gains in North America where margins are more attractive. Management attributes margin resilience in Additives & Functional Products to a portfolio where two-thirds of revenue serves stable markets like pharma and aviation, supported by cost pass-through contracts. The company successfully implemented price increases to cover rising raw material, energy, and distribution costs, maintaining variable margins per kilogram consistent with 2019 levels. Operational improvements in Performance Films, including a new market strategy and cost optimization in China, significantly contributed to the sequential earnings recovery from Q1 to Q2. Management expects Q3 volumes to remain sequentially similar to Q2, representing a substantial year-over-year increase due to innovation wins rather than a recovery in underlying market demand. The circular economy platform is projected to deliver over $100 million in revenue growth for the full year, with momentum expected to accelerate in the second half as rPET capacity ramps up. Asset utilization is expected to flip from a first-half headwind to a second-half tailwind as the company converts pre-purchased raw materials into finished goods to meet solid demand. Fibers segment earnings are anticipated to improve in the back half of the year as customers increase orders to meet annual minimum volume commitments. The company is developing a more capital-efficient model for future methanolysis investments, pushing major new capital spending to 2028 by debottlenecking the existing Kingsport facility by 30%. Middle East conflict remains a primary source of uncertainty, with management monitoring potential impacts on global consumer demand and energy costs, though no material impact was seen in Q2. A massive planned shutdown of the cellulose stream in Q2 acted as a significant headwind but is expected to provide a favorable year-over-year comparison in 2027. Working capital management remains a priority, though the company expects to recover less cash from working capital this year compared to last due to the stronger second-half growth profile. Textile volumes remain challenged by weak market demand and tariffs, leading management to pivot toward share recovery and new growth programs like Aventa to stabilize the cellulosic stream. Management is not forecasting an improvement in weak discretionary markets like auto or durables for the back half of the year. Growth is being driven by innovation wins and the ramp-up of the circular business, which should keep volumes stable sequentially despite typical seasonal declines. One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here. The volume increase was primarily due to the absence of the significant planned and unplanned shutdowns that occurred in the prior year. Eastman captured higher-margin share in North America and liquidated stored ethylene at attractive prices due to market tightness. The slight reduction in the revenue outlook for the circular business is split between production capacity constraints and a general slowness in the weak global economy. Management emphasized that no customers are backing away from recycled content commitments, and the value proposition for rPET remains superior to mechanical recycling. The Kingsport plant is running with yields above 90%, proving the technical viability of the platform despite a difficult macro environment. Future investments will follow a more capital-efficient path, utilizing debottlenecking to delay large-scale capital expenditures until market demand further matures. M&A activity has increased this year as valuations have become more rational compared to recent years. Management remains open to both acquisitions and divestments but will maintain strict discipline, focusing on businesses that support the innovation-driven growth model.

Interested in Eastman Chemical Company? Here are five stocks we like better. Eastman expects stronger earnings growth in the second half of 2026, driven by volume gains, improved asset utilization and price-cost benefits. However, management does not anticipate a broad recovery in weak discretionary markets such as automotive and consumer durables. Advanced Materials posted 5% second-quarter volume growth, supported by innovation wins, while new Tritan capacity and circular-products growth are expected to aid second-half results. Eastman modestly lowered its circular-revenue outlook because of rPET production constraints and customers’ greater sensitivity to recycled-content premiums. Eastman remains committed to its methanolysis recycling platform, with the Kingsport facility operating above 90% yields and a potential 30% capacity increase. The company is also targeting $125 million to $150 million in net cost reductions in 2026 as it manages higher capital costs and uncertain market conditions. Stock ideas from the 2024 Microcap Conference Eastman Chemical (NYSE:EMN) said it expects stronger earnings growth in the second half of 2026 than it anticipated in April, citing volume gains, improved asset utilization and price-cost benefits across its specialty businesses. During its second-quarter earnings call, Chief Executive Officer Mark Costa said the company is not forecasting a broad recovery in weak discretionary markets such as automotive, consumer durables and certain aftermarket categories. “We’re not expecting any improvement in the end markets” tied to weak discretionary demand, Costa said. However, he said Eastman continues to see modest growth in stable end markets and has not yet observed a material demand impact from the Middle East conflict. → Why SK hynix Could Be the Best AI Chip Stock to Buy Now High-Growth, High-Yield Value Stocks Nearing Trigger Points Eastman reported 5% volume growth in its Advanced Materials segment during the second quarter, which Costa attributed largely to innovation-driven commercial wins. He said third-quarter volumes are expected to be roughly consistent sequentially with the second quarter, while remaining substantially above year-earlier levels. The company expects Advanced Materials earnings to benefit in the second half from higher production utilization, pricing actions and growth in its circular-products platform. Eastman had reduced finished-goods inventory during the first half while securing supplies of paraxylene, creating a utilization headwind that Costa said should reverse as the company converts those materials into finished goods. → Microsoft Just Flipped the AI Spending Narrative Overnight Costa also said a new Tritan production line is coming online as Eastman had been constrained by Tritan capacity and had shifted one existing line to serve polyethylene terephthalate, or PET, growth. The company expects price-cost dynamics in the segment to become a tailwind in the second half as previously implemented price increases catch up with raw-material costs. For Eastman’s Renew portfolio, Costa said revenue growth exceeded $100 million in the first half and more than doubled from the prior year. Growth was roughly evenly split between specialty products and recycled PET, or rPET, although specialty products accounted for more of the first-half contribution and PET is expected to account for more of the second-half ramp. → Carrier Earnings Could Send the Stock to a New All-Time High Eastman modestly lowered its circular-revenue outlook to below the range previously provided, citing both rPET production limitations and slower customer purchasing. Costa said customers remain committed to recycled content, but a weak economy has made them more disciplined about the premiums they pay. “We’re not seeing anyone back away from their commitments to recycled content,” Costa said. He added that demand for Eastman’s rPET supports the company’s view that its product offers better quality and clarity than mechanically recycled alternatives. Costa rejected the view that Eastman has materially redirected its strategy away from methanolysis, the chemical recycling process used at its Kingsport facility. He said the company continues to view the technology as a significant long-term growth platform, despite a weaker economy and increased capital costs. The Kingsport methanolysis plant is operating reliably, with yields above 90%, according to Costa. Eastman believes it can debottleneck the facility by 30% to reach 130,000 tons of capacity, or 130% of design capacity. Costa said the asset had been operating at about 50% utilization last year and utilization has increased with improved demand in 2026. Polymer capacity, rather than methanolysis capacity, is currently the constraint for rPET growth, Costa said. Eastman is evaluating additional ways to optimize polymer assets to support further PET production next year. Regarding a potential Texas project, Costa said higher capital costs and the loss of a Department of Energy grant prompted Eastman to develop a more capital-efficient approach. The company expects to provide additional details later and said the Kingsport expansion opportunity allows it to push out the next major capital commitment until 2028. Eastman still expects the first circular asset to eventually generate $200 million of EBITDA, although Costa said reaching that level will take longer than previously hoped because of current economic conditions. He said circular-products margins are above the company average but did not provide a contribution-margin figure. In Chemical Intermediates, Costa said most of the year-over-year volume increase reflected the absence of major planned and unplanned shutdowns that limited production in the prior year. Eastman also gained some North American share in higher-margin markets and sold stored ethylene into what Costa described as attractive market conditions. He cautioned that Chemical Intermediates spreads could moderate in the second half and described the outlook as highly uncertain because of developments involving the Middle East and the Strait of Hormuz. Eastman expects to retain most of the volume share it gained, though the profitability of that volume could change with market spreads. Advanced Additives & Functional Products continued to show resilient margins, supported by a portfolio weighted toward stable markets including pharmaceuticals, water treatment, agriculture, personal care and aviation, Costa said. He pointed to favorable industry structures, strong competitive positions and cost-passthrough arrangements in certain businesses. Eastman intends to maintain specialty-product prices as higher raw-material, energy and distribution costs continue to flow through. In Fibers, Eastman expects tow volumes to rise materially in the second half as customers increase purchases to meet annual minimum-volume commitments. Costa said annual tow volumes should be relatively stable compared with last year. Textile volumes, which were weak in the first half, are expected to improve enough in the second half to bring the business roughly even with 2025 levels. Chief Financial Officer Willie McLain said Eastman remains on track to deliver $125 million to $150 million of cost reductions net of inflation in 2026. The largest benefits are expected in Advanced Materials and Chemical Intermediates, with smaller contributions from Fibers and Additives & Functional Products. He said the company’s focus for 2027 will include at least offsetting inflation. McLain said higher pricing is expected to add about $500 million to revenue this year. Working capital consumed less cash in the first half than in the prior-year period, although Eastman expects to recover less working capital in the second half than it did last year. McLain said the company expects to approach $900 million, compared with $970 million under the company’s prior comparison. Eastman completed a major maintenance shutdown of its Kingsport coal gasifier and related stream in the second quarter. Costa said the work was a significant sequential headwind for Fibers and Chemical Intermediates, but its cost will not repeat next year. On acquisitions and divestitures, Costa said Eastman is evaluating opportunities as industry activity increases and valuations become more rational. He emphasized that the company will remain disciplined, citing its past acquisitions, divestitures of underperforming businesses and continuing investment in organic growth through innovation. Eastman Chemical Company (NYSE: EMN) is a global specialty materials company that develops, manufactures and markets a broad range of advanced materials, chemicals and fibers. Its product portfolio spans performance additives, functional products, and engineered plastics designed to enhance the durability, appearance and performance of end products across diverse industries. The company's main business activities include the production of specialty chemicals used in adhesives, coatings, building materials and consumer care applications, as well as high-performance plastics for packaging, automotive and electronics markets. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. The article "Eastman Chemical Q2 Earnings Call Highlights" was originally published by MarketBeat. View MarketBeat's top stocks for July 2026.

Eastman Chemical Company EMN reported adjusted earnings of $1.97 per share for the second quarter of 2026, up 23.1% from $1.60 a year ago. The figure beat the Zacks Consensus Estimate of $1.80 by 9.4%. Sales rose 9.9% year over year to $2,513 million and surpassed the consensus estimate of $2,367.3 million by 6.2%. Higher volume/mix and selling prices supported the top line, led by a sharp improvement in Chemical Intermediates. Companywide sales volume/mix increased 5%, while selling prices rose 4%. Advanced Materials and Chemical Intermediates recorded higher volume/mix, partly offset by weakness in Fibers. Chemical Intermediates pricing benefited from tightening market conditions tied to the Middle East conflict, while specialty-business price increases offset higher raw material and distribution costs. Eastman Chemical Company price-consensus-eps-surprise-chart | Eastman Chemical Company Quote Advanced Materials sales increased 5% year over year to $817 million from $777 million. The improvement reflected 4% higher volume/mix, driven by growth across the segment, and a 1% favorable currency impact. Price-cost was stable as specialty-plastics price increases offset modestly weaker price-cost in advanced interlayers. Additives & Functional Products revenues rose 5% to $807 million from $769 million. The increase was primarily driven by 4% higher selling prices related to cost-pass-through contracts, along with a 1% favorable foreign-currency effect. Chemical Intermediates sales surged 39% to $643 million from $463 million. Volume/mix increased 24%, while selling prices advanced 14%. Higher availability and supply disruptions supported volumes and pricing, particularly for olefin and derivative products. Fibers revenues declined 11% to $243 million from $274 million. Volume/mix fell 10% due to continued acetate tow inventory destocking and weakness in textiles compared with tariff-related volume strength in the prior-year period. Selling prices decreased 2%, partly reflecting lower acetate tow contract pricing. Eastman ended the second quarter with cash and cash equivalents of $691 million. Total borrowings were $5,217 million as of June 30, 2026. Net debt was $4,526 million at quarter end. Cash provided by operating activities was $224 million. The company returned $96 million to stockholders through dividends and did not repurchase shares during the quarter. For 2026, Eastman expects earnings to improve significantly from 2025. The company remains on track to deliver cost reductions of $125 million to $150 million, net of inflation, and continues to project capital expenditures of approximately $400 million. Operating cash flow is now expected to approach $900 million, modestly below the prior expectation of approaching the 2025 level. For the third quarter, adjusted earnings are projected to approach the second-quarter level of $1.97 per share. Advanced Materials EBIT is expected to increase on improved price-cost and asset utilization, while Fibers earnings should benefit from higher acetate tow purchases. Additives & Functional Products earnings are expected to decline modestly due to seasonal agriculture weakness, while Chemical Intermediates earnings are projected to ease as supply-chain disruptions lessen. EMN’s shares have gained 19.2% over a year compared with the 7% growth recorded by the Zacks Chemicals Diversified industry. Image Source: Zacks Investment Research EMN currently carries a Zacks Rank #4 (Sell). Some better-ranked stocks in the basic materials space are The Chemours Company CC, Kronos Worldwide, Inc. KRO and Avient Corporation AVNT. Chemours is slated to report second-quarter 2026 results on Aug. 4. The Zacks Consensus Estimate for earnings is pegged at 43 cents per share. CC sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here. Kronos is scheduled to report second-quarter 2026 results on Aug. 5. The Zacks Consensus Estimate for KRO’s second-quarter loss per share is pegged at 33 cents, indicating 65.63% year-over-year growth. KRO also flaunts a Zacks Rank #1 at present. Avient is slated to report second-quarter 2026 results on Aug. 6. The consensus estimate for AVNT’s earnings per share is pegged at $3.08. AVNT presently carries a Zacks Rank #2 (Buy). Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Eastman Chemical Company (EMN) : Free Stock Analysis Report Kronos Worldwide Inc (KRO) : Free Stock Analysis Report The Chemours Company (CC) : Free Stock Analysis Report Avient Corporation (AVNT) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

Eastman Chemical (EMN) reported $2.51 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 9.9%. EPS of $1.97 for the same period compares to $1.60 a year ago. The reported revenue represents a surprise of +6.16% over the Zacks Consensus Estimate of $2.37 billion. With the consensus EPS estimate being $1.80, the EPS surprise was +9.44%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how Eastman Chemical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Sales- Additives & Functional Products: $807 million versus the four-analyst average estimate of $772.01 million. The reported number represents a year-over-year change of +4.9%. Net Sales- Fibers: $243 million versus the four-analyst average estimate of $249.74 million. The reported number represents a year-over-year change of -11.3%. Net Sales- Chemical Intermediates: $643 million versus the four-analyst average estimate of $513.13 million. The reported number represents a year-over-year change of +38.9%. Net Sales- Advanced Materials: $817 million versus the four-analyst average estimate of $810.28 million. The reported number represents a year-over-year change of +5.2%. Net Sales- Other: $3 million versus $3.5 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -25% change. Adjusted EBIT- Additives & Functional Products: $151 million versus $137.34 million estimated by four analysts on average. Adjusted EBIT- Advanced Materials: $109 million versus $106.75 million estimated by four analysts on average. Adjusted EBIT- Chemical Intermediates: $58 million versus the four-analyst average estimate of $36.79 million. Adjusted EBIT- Other: $-34 million versus $-37.71 million estimated by four analysts on average. Adjusted EBIT- Fibers: $36 million versus the four-analyst average estimate of $50.12 million. View all Key Company Metrics for Eastman Chemical here>>> Shares of Eastman Chemical have returned +0.3% over the past month versus the Zacks S&P 500 composite's -1.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Eastman Chemical Company (EMN) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

Eastman Chemical (EMN) came out with quarterly earnings of $1.97 per share, beating the Zacks Consensus Estimate of $1.8 per share. This compares to earnings of $1.6 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +9.44%. A quarter ago, it was expected that this specialty chemicals maker would post earnings of $1.07 per share when it actually produced earnings of $1.09, delivering a surprise of +1.87%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Eastman Chemical, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $2.51 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 6.16%. This compares to year-ago revenues of $2.29 billion. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Eastman Chemical shares have added about 5.4% since the beginning of the year versus the S&P 500's gain of 6.9%. While Eastman Chemical has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Eastman Chemical was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.81 on $2.38 billion in revenues for the coming quarter and $6.30 on $9.06 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Diversified is currently in the top 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Another stock from the same industry, Tronox (TROX), has yet to report results for the quarter ended June 2026. The results are expected to be released on August 5. This producer of titanium ore and titanium dioxide is expected to post quarterly loss of $0.39 per share in its upcoming report, which represents a year-over-year change of -39.3%. The consensus EPS estimate for the quarter has been revised 35% lower over the last 30 days to the current level. Tronox's revenues are expected to be $848.78 million, up 16.1% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Eastman Chemical Company (EMN) : Free Stock Analysis Report Tronox Holdings PLC (TROX) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

KINGSPORT, Tenn., July 30, 2026--(BUSINESS WIRE)--Eastman Chemical Company (NYSE:EMN) announced its second-quarter 2026 financial results. Delivered strong sequential EPS growth and solid cash flow in a dynamic environment through commercial and operational excellence Drove a 350-basis-point sequential adjusted EBIT margin improvement through 8% higher sales volume/mix and disciplined price-cost management in Advanced Materials and Additives & Functional Products and spread expansion in Chemical Intermediates Continued to leverage our significant and advantaged integrated U.S.-based assets to be a reliable supplier to our customers amid an uncertain global environment Building strategic momentum in the circular platform, doubled revenue in the first half of the year and continued great operational performance Made substantial progress toward delivering $125 million to $150 million of cost savings, net of inflation Remained focused on delivering solid operating cash flow and expect to release working capital in the second half of 2026 "The Eastman team delivered a strong second quarter despite continued dynamic macroeconomic conditions," said Mark Costa, Board Chair and CEO. "Sales revenue increased 15 percent sequentially driven by strong volume growth across the company and disciplined price-cost management in our specialty businesses. We also delivered strong spread expansion and volume/mix improvement in Chemical Intermediates. These actions resulted in a 350-basis-point sequential increase in our EBIT margin. We also continued to successfully manage the impact of the conflict in the Middle East and secured supply of key raw materials to help customers navigate the uncertainty. Additionally, we built momentum with the commercial ramp up of the Kingsport methanolysis facility and are making progress on a capital-efficient set of options to serve the packaging market." Corporate Results 2Q 2026 versus 2Q 2025 Sales revenue increased 10 percent primarily due to 5 percent higher sales volume/mix and 4 percent higher selling prices. Higher sales volume/mix in Advanced Materials and Chemical Intermediates was partially offset by Fibers. Higher selling prices in Chemical Intermediates were primarily driven by tightening market conditions due to the ongoing Middle East conflict. Higher selling prices in specialty businesses offset higher raw material and distribution costs. EBIT increased due to favorable price-cost, the benefit from cost-reduction initiatives, favorable foreign currency exchange rates and higher sales volume/mix. These factors were partially offset by higher variable compensation expense, higher planned maintenance expense and unfavorable asset utilization. Segment Results 2Q 2026 versus 2Q 2025 Advanced Materials – Sales revenue increased 5 percent due to 4 percent higher sales volume/mix and 1 percent favorable foreign currency exchange rates. Higher sales volume/mix was driven by growth across the segment. Price-cost was stable as increases in specialty plastics to mitigate higher raw material and distribution costs were offset by modestly lower price-cost in advanced interlayers. EBIT decreased as higher sales volume/mix, favorable foreign currency exchange rates and cost reduction initiatives were more than offset by lower asset utilization and higher variable compensation expense. Additives & Functional Products – Sales revenue increased 5 percent primarily due to 4 percent higher selling prices. Higher selling prices were primarily driven by cost-pass-through contracts. EBIT was relatively unchanged as improved price-cost, favorable foreign currency exchange rates and cost reduction initiatives were offset by higher planned maintenance expense. Fibers – Sales revenue decreased 11 percent primarily due to 10 percent lower sales volume/mix and 2 percent lower selling prices. Lower sales volume/mix was driven by customer buying patterns to continue with inventory destocking in acetate tow and continued weakness in the textiles end market relative to tariff-driven volume strength last year. EBIT decreased due to lower sales volume/mix, modestly lower acetate tow contract pricing, higher operating costs including lower asset utilization, and elevated costs associated with logistics to serve customers in connection with the Middle East conflict. These were partially offset by the benefit of cost reduction initiatives. Chemical Intermediates – Sales revenue increased by 39 percent primarily due to 24 percent higher sales volume/mix and 14 percent higher selling prices. Higher sales volume/mix and selling prices, particularly for olefin and derivative products, were driven by increased volume availability compared to the prior year period and supply disruptions. EBIT increased due to higher spreads, improved volume/mix and cost-reduction initiatives. Cash Flow In second quarter 2026, cash provided by operating activities was $224 million versus $233 million in second quarter 2025. The company returned $96 million to stockholders through dividends. See Table 5. Priorities for uses of available cash for 2026 include payment of the quarterly dividend, capital expenditures, and share repurchases while maintaining our solid investment-grade balance sheet. 2026 Outlook Commenting on the outlook for full-year 2026, Costa said: "Our team has demonstrated agility in the first half and is focused on building on the momentum and solid results delivered in the first half of 2026, despite the constantly changing impact of the Middle East conflict and continued weak demand in key discretionary end markets. We remain focused on driving growth through innovation, which is expected to be the primary driver of our specialty growth for the year. A key contributor to our innovation-driven growth is our Kingsport methanolysis facility, which continues to build strategic momentum. We also delivered solid growth through our innovation across weak discretionary end markets. We continue to see modest growth across stable end markets. Our commercial teams demonstrated excellence in successfully implementing price increases in our specialties to offset higher raw material and distribution costs and expect a modest tailwind from these actions in the back half. In our Chemical Intermediates segment, we have benefited from significant spread expansion due to the impact on supply chains of the Middle East conflict and substantially more volume to sell this year. We also remain on track to reduce costs between $125 million and $150 million, net of inflation, and are maintaining disciplined capital expenditures by spending approximately $400 million this year. When putting all of these factors together, we remain confident we can significantly improve earnings in 2026 versus 2025. On cash, the inflationary environment is putting pressure on accounts receivable. As a result, we now expect operating cash flow to approach $900 million, which is modestly below our previous expectation of approaching 2025 levels. "Looking specifically at the sequential third-quarter 2026 outlook, we start with Advanced Materials, where we expect EBIT to be higher driven by improved price-cost and improved asset utilization. We also expect higher earnings in Fibers as acetate tow volume increases, with customers increasing purchases to meet their annual contracts. Additives & Functional Products earnings are expected to decline modestly due to seasonally lower volume, particularly in the agriculture market. Chemical Intermediates earnings are expected to modestly decline as the impact of supply chain disruptions lessens. When putting these factors together, we project third-quarter adjusted EPS to approach second-quarter 2026 EPS of $1.97." The third-quarter 2026 projected adjusted diluted EPS excludes any non-core, unusual, or nonrecurring items. Our financial results forecasts do not include non-core items (such as mark-to-market pension and other post-retirement benefit gain or loss, and asset impairments and restructuring charges) or any unusual or non-recurring items because we are unable to predict with reasonable certainty the financial impact of such items. These items are uncertain and depend on various factors, and we are unable to reconcile projected adjusted diluted EPS excluding non-core and any unusual or non-recurring items to reported GAAP diluted EPS without unreasonable efforts. Forward-Looking Statements The information in this release and other statements by the company may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to, among other items: projections and estimates of earnings, revenues, volumes, pricing, margins, sales, cost reductions, expenses, taxes, liquidity, capital expenditures, cash flow, dividends, share repurchases or other financial items, supply and demand, capacity and utilization, growth opportunities, statements of management’s plans, strategies and objectives for future operations, and statements regarding future economic, industry or market conditions or performance. Such projections and estimates are based upon certain preliminary information, internal estimates, and management assumptions, expectations, and plans. Forward-looking statements are subject to a number of risks and uncertainties, and actual performance or results could differ materially from that anticipated by any forward-looking statements. Forward-looking statements speak only as of the date they are made, and the company undertakes no obligation to update or revise any forward-looking statement. Other important assumptions and factors that could cause actual results to differ materially from those in the forward-looking statements are detailed in the sections entitled "Risk Factors" and "Management’s Discussion and Analysis of Financial Condition and Results of Operations" in the company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and as updated in the company’s filings with the Securities and Exchange Commission (the "SEC"), which are accessible on the SEC’s website at www.sec.gov and the company’s website at www.eastman.com. Financial Measures (Non-GAAP) In addition to the financial information presented in accordance with Generally Accepted Accounting Principles ("GAAP"), this press release includes the following non-GAAP financial measures: adjusted EBIT, adjusted EBIT margin, and adjusted earnings per diluted share. We define adjusted EBIT as the GAAP measure EBIT adjusted for non-core, unusual, or non-recurring items. Adjusted earnings per diluted share is defined as the GAAP measure earnings per diluted share adjusted for non-core, unusual, or non-recurring items. Adjusted EBIT margin is defined as adjusted EBIT divided by the GAAP measure sales revenue in the Company's Unaudited Consolidated Statement of Earnings, Comprehensive Income and Retained Earnings for the same periods. See the reconciliation tables presented in this release for a detailed reconciliation of non-GAAP financial measures to the most directly comparable GAAP measure. We believe that in addition to our results determined in accordance with GAAP, these non-GAAP financial measures provide useful information to both management and investors in measuring our financial performance and highlight trends in our business that may not otherwise be apparent when relying solely on GAAP measures. These non-GAAP financial measures provide supplemental information regarding our operating performance that excludes certain gains, losses and non-cash charges that occur relatively infrequently and/or that we consider to be unrelated to our core operations. Non-GAAP financial information is presented for supplemental informational purposes only and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Our presentation of non-GAAP measures should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items. Other companies in our industry may calculate these measures differently, which may limit their usefulness as comparative measures. Conference Call and Webcast Information Eastman will host a conference call with industry analysts on July 31, 2026, at 8:00 a.m. ET. To listen to the live webcast of the conference call and view the accompanying slides and prepared remarks, go to investors.eastman.com, Events & Presentations. The slides and prepared remarks to be discussed during the call and webcast will be available at investors.eastman.com at approximately 4:15 p.m. ET on July 30, 2026. To listen via telephone, the dial-in number is +1 (833) 470-1428, passcode: 385739. A web replay, a replay in downloadable MP3 format, and the accompanying slides and prepared remarks will be available at investors.eastman.com, Events & Presentations. A telephone replay will be available continuously beginning at approximately 1:00 p.m. Eastern Time, July 31, through 11:59 p.m. Eastern Time, August 10, 2026, Toll Free at +1 (866) 813-9403, passcode 129897. Founded in 1920, Eastman is a global specialty materials company that produces a broad range of products found in items people use every day. With the purpose of enhancing the quality of life in a material way, Eastman works with customers to deliver innovative products and solutions while maintaining a commitment to safety and sustainability. The company’s innovation-driven growth model takes advantage of world-class technology platforms, deep customer engagement, and differentiated application development to grow its leading positions in attractive end markets such as transportation, building and construction, and consumables. As a globally inclusive company, Eastman employs approximately 13,000 people around the world and serves customers in more than 100 countries. The company had 2025 revenue of approximately $8.8 billion and is headquartered in Kingsport, Tennessee, USA. For more information, visit www.eastman.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260730556159/en/ Contacts Media: Tracy Kilgore Addington423-224-0498 / [email protected] Investors: Greg Riddle212-835-1620 / [email protected]

Methanex (MEOH) came out with quarterly earnings of $3.87 per share, missing the Zacks Consensus Estimate of $4 per share. This compares to earnings of $0.97 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -3.25%. A quarter ago, it was expected that this methanol supplier would post earnings of $0.47 per share when it actually produced earnings of $0.3, delivering a surprise of -36.17%. Over the last four quarters, the company has not been able to surpass consensus EPS estimates. Methanex, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $1.4 billion for the quarter ended June 2026, missing the Zacks Consensus Estimate by 1.36%. This compares to year-ago revenues of $797 million. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Methanex shares have added about 36.4% since the beginning of the year versus the S&P 500's gain of 8.3%. While Methanex has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Methanex was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $2.87 on $1.22 billion in revenues for the coming quarter and $9.18 on $4.82 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Diversified is currently in the top 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Eastman Chemical (EMN), another stock in the same industry, has yet to report results for the quarter ended June 2026. The results are expected to be released on July 30. This specialty chemicals maker is expected to post quarterly earnings of $1.80 per share in its upcoming report, which represents a year-over-year change of +12.5%. The consensus EPS estimate for the quarter has been revised 5% lower over the last 30 days to the current level. Eastman Chemical's revenues are expected to be $2.37 billion, up 3.5% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Methanex Corporation (MEOH) : Free Stock Analysis Report Eastman Chemical Company (EMN) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

Wall Street expects a year-over-year increase in earnings on higher revenues when LyondellBasell (LYB) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 31. On the other hand, if they miss, the stock may move lower. While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. This oil refiner and chemical company is expected to post quarterly earnings of $3.56 per share in its upcoming report, which represents a year-over-year change of +474.2%. Revenues are expected to be $8.9 billion, up 16.2% from the year-ago quarter. The consensus EPS estimate for the quarter has been revised 21.38% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts. Price, Consensus and EPS Surprise Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only. A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP. Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). For LyondellBasell, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -5.07%. On the other hand, the stock currently carries a Zacks Rank of #3. So, this combination makes it difficult to conclusively predict that LyondellBasell will beat the consensus EPS estimate. While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. For the last reported quarter, it was expected that LyondellBasell would post earnings of $0.31 per share when it actually produced earnings of $0.49, delivering a surprise of +58.06%. Over the last four quarters, the company has beaten consensus EPS estimates two times. An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. LyondellBasell doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release. Among the stocks in the Zacks Chemical - Diversified industry, Eastman Chemical (EMN), is soon expected to post earnings of $1.8 per share for the quarter ended June 2026. This estimate indicates a year-over-year change of +12.5%. This quarter's revenue is expected to be $2.37 billion, up 3.5% from the year-ago quarter. Over the last 30 days, the consensus EPS estimate for Eastman Chemical has been revised 4.9% down to the current level. Nevertheless, the company now has an Earnings ESP of +0.93%, reflecting a higher Most Accurate Estimate. When combined with a Zacks Rank of #4 (Sell), this Earnings ESP makes it difficult to conclusively predict that Eastman Chemical will beat the consensus EPS estimate. Over the last four quarters, the company surpassed EPS estimates just once. Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report LyondellBasell Industries N.V. (LYB) : Free Stock Analysis Report Eastman Chemical Company (EMN) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research